Find your path to Catherine
257 people in our graph share verified history with Catherine — schools, employers, funds. One of them is your warm intro.
Mojca SkoberneunlockedCatherine: together at Rockefeller University
×8Catherine: together at Bayer Biotechnology
×2Catherine: together at Rockefeller University
Catherine: together at Kalamazoo College
Chief Development Officer at Neurona Therapeutics
Intro paths
→
In turn, Catherine can intro founders to Neurona Therapeutics's investors below.
Neurona Therapeutics's investors · 14
AlexandriaPasadena · since 2025Berkeley FrontierBerkeley · since 2025Fidelity InvestmentsBoston · since 2025Iaso VenturesCambridgeLYFE CapitalMenlo Park · since 2025Soleus CapitalGreenwich · since 2025Spur Capital PartnersBoston · since 2025SymBiosisBentonville · since 2024The Column GroupSan Francisco · $30M checks · since 2025UCB VenturesBrussels · since 2025Viking Global InvestorsStamford · since 2025Willett AdvisorsNew York · since 2025YK BioventuresBurlingame · since 2025Ysios CapitalBarcelona · $5.4M – $21.6M checks · since 2025
Co-founders at Neurona Therapeutics
CN

Cory NicholasExecutive Officer, Director, Promoter
Experience
- Neurona TherapeuticsChief Development Officer (CDO)current2021 — presentSan Francisco Bay Area
- Neurona TherapeuticsVP, Preclinical Development2015 — 2021San Francisco Bay Area
- California Institute for Regenerative MedicineSenior Science Officer2012 — 2015San Francisco Bay Area
- GeronSenior Director2008 — 2012San Francisco Bay Area
- GeronDirector2007 — 2008San Francisco Bay Area
- GeronAssociate Director2005 — 2007San Francisco Bay Area
- GeronGroup Leader2004 — 2005San Francisco Bay Area
- GeronSenior Scientist II2002 — 2004San Francisco Bay Area
- Bayer BiotechnologySenior Research Scientist I, II2001 — 2002San Francisco Bay Area
- University of Maryland School of MedicineAssistant Professor1997 — 2001Washington DC-Baltimore Area
- Icahn School of Medicine at Mount SinaiAdjunct Assistant Professor1997 — 1999New York City Metropolitan Area
- Icahn School of Medicine at Mount SinaiPostdoctoral Research Scientist1995 — 1997New York City Metropolitan Area
- Rockefeller UniversityPostdoctoral Research Scientist1994 — 1995New York City Metropolitan Area
Skills & more
Stem Cells29Cell Culture25Neuroscience16Clinical Development17Histology14Regenerative Medicine9Biotechnology10CRO5Regulatory Submissions6Drug Discovery10Cell Biology7Spinal Cord Injury2
+8 more
NeuroanatomyCell TherapyPreclinical DevelopmentImmunohistochemistryin Situ HybridizationDrug DevelopmentMolecular BiologyCellular TherapeuticsFrom Catherine's professional profile.
Frequently asked questions
- Who is Catherine Priest?
- Chief Development Officer at Neurona Therapeutics
- Where does Catherine Priest work?
- Catherine Priest is Chief Development Officer at Neurona Therapeutics.
- Where did Catherine Priest go to school?
- Catherine Priest studied at Kalamazoo College (B.A., Biology, Psychology); UCLA (Ph.D., Neuroscience, Anatomy, Cell Biology).
Same school
Also attended Kalamazoo College20
Jack SmithMBA Associate at Energy Capital VenturesLawrence CarterFellow at High Street Equity PartnersJason BarnettSenior Vice President, Lending at Invest DetroitSamer YaghnamChief Operations Officer at The Olayan GroupCharles StackInvestor at FlashStartsDan HoevelManaging Director and Head of Fundraising & Investor Relations at Silver Lake Partners
+ 14 more
Also attended UCLA1,017
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzKirsten GreenFounder and Managing Partner at Forerunner VenturesVlad TenevCo-founder & CEO of RobinhoodRyan KingCo-founder of ChimePaul FieldingFinance & Operations at General CatalystMelody MaExecutive Assistant and Lead Receptionist at Trinity Ventures
+ 1,011 more
Shared employers
Also worked at Neurona Therapeutics3
Also worked at California Institute for Regenerative Medicine8
Maria MillanInvestor at DigitalDx VenturesNeil LittmanManaging Partner at BiovergeZach ScheinerPartner at RA CapitalShannon DahlChief Scientific Officer at IolyxEric SchulzeScientist, executive, and former FDA regulator (cultivated meat lead) at Evergreen SelectTed W. LoveExecutive Officer, Director at Global Blood Therapeutics
+ 2 more
Also worked at Geron8
Joyce BremerInvestor at True VenturesMelissa LezametaAssociate at Epidarex CapitalDaniel BradburyInvestor at BioBritNam KimExecutive Officer, Director at KDx DiagnosticsJim HassardEVP, Chief Commercial Officer at Aligos TherapeuticsMichelle J. RobertsonExecutive Vice President, Chief Financial Officer, Treasurer and Interim Secretary at Geron
+ 2 more
Also worked at Bayer Biotechnology149
Vincent RoseInvestment Manager at Burda Principal InvestmentsBenjamin BrockwellVenture Partner at Copper Sky CapitalAxel BouchonVenture Partner at ARCH Venture PartnersVincent RulandEntrepreneur-in-Residence at Versant VenturesAtsushi ShimadaSenior Principal at AN Venture PartnersMelike Abacioglu GunesVP of Marketing at Asymmetric Capital Partners
+ 143 more



































